Dental Care Clinics in Trujillo Alto, PR Accepting Medicare
5 Dental Care Clinics found. Showing 1 - 5
 Trujillo Dental Clinic Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: Calle Dr. Fernandez, #206, Trujillo Alto, PR 00976 Phone: 787-755-3045 Fax: 787-292-0277 |
Trujillo Dental Clinic Psc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 206 Calle Dr Fernandez, 206 Dr Fernandez, Trujillo Alto, PR 00976 Phone: 787-755-3045 Fax: 787-292-0277 |
Dr Brenda Latorre Psc Dentist Dentist Medicare: Not Enrolled in Medicare Practice Location: Expreso Trujillo Alto Int Carr #850, Bo Las Cuevas Tercer Piso, Trujillo Alto, PR 00976 Phone: 787-283-1420 Fax: 787-760-6652 |
Dental Pmb Llc Dentist Medicare: Not Enrolled in Medicare Practice Location: 4 Edificio Centro Suite 209, Trujillo Alto, PR 00976 Phone: 787-755-3105 |
Neomed Center - Trujillo Alto Dental Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 130 Calle Carite, Urb. Lago Alto, Trujillo Alto, PR 00976 Phone: 787-737-2311 Fax: 787-737-0244 |
News Archive
Hill-Rom Hand Hygiene Compliance Solution increases hand washing among hospital staff
New data from Hill-Rom shows its hand-hygiene compliance system dramatically increases hand washing among hospital staff using the system. Analysis of more than 20 million instances of hand washing shows institutions using Hill-Rom's Hand Hygiene Compliance Solution have achieved an average 226% improvement in compliance, with some institutions showing compliance by caregivers nearly tripled.
Norovirus still at Christchurch Hospital
Members of the public are asked not to go to the Emergency Department at New Zealand's Christchurch hospital if they have symptoms of Norovirus – vomiting and diarrhoea.
ESSA reports net loss of $11.5 million for year ended September 30, 2015
ESSA Pharma Inc. today reported financial results for the year ended September 30, 2015. Amounts, unless specified otherwise, are expressed in Canadian dollars and in accordance with International Financial Reporting Standards ("IFRS").
Phase I study of Shigella dysenteriae bioconjugate vaccine meets primary, secondary endpoints
GlycoVaxyn AG, a leader in the development of innovative vaccines, announced today that the Phase I study of its Shigella dysenteriae bioconjugate vaccine has been completed and met the primary and secondary endpoints: demonstration of safety and immunogenicity.
Neuren granted US patent for NNZ-2566
Neuren Pharmaceuticals has announced that its patent application entitled "GPE Analogs and Peptidomimetics" (PCT/US02/16361) has been issued in the United States (US Patent No: 7,041,314) on 9 May 2006.
› Verified 7 days ago